Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines

Bioorg Med Chem. 2005 May 16;13(10):3487-95. doi: 10.1016/j.bmc.2005.02.061.

Abstract

Modification of cysteine (Cys) residues inactivates monoamine oxidases (MAO) yet the crystal structure shows no conserved cysteines in the active site of MAO A (Ma, J. et al. J. Mol. Biol.2004, 338, 103-114). MAO A cysteine 374 was mutated to alanine and the purified enzyme characterized kinetically. The mutant was active but had decreased k(cat)/K(m) values compared to the wild-type enzyme. Cyclopropylamine-containing mechanism-based inactivators similarly showed lower turnover rates. Spectral studies and measurement of free thiols established that 1-phenylcyclopropylamine (1-PCPA) formed an irreversible flavin adduct whereas 2-phenylcyclopropylamine (2-PCPA) and N-cyclo-alpha-methylbenzylamine (N-CalphaMBA) formed adducts that allowed reoxidation of the flavin on denaturation and decreased cysteine in both wild-type and mutant MAO A. In the 1-PCPA and N-CalphaMBA inactivations, the partition ratio was decreased by more than 50% in the mutant. The data suggest that mutation of Cys374 influences MAO A catalysis, which has implications for MAO susceptibility to redox damage. These results are compared with previous work on the equivalent residue in MAO B, namely, cysteine 365.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / metabolism
  • Alanine / chemistry*
  • Alanine / genetics
  • Benzylamines / metabolism
  • Binding Sites
  • Catalysis
  • Cyclopropanes / chemistry
  • Cyclopropanes / pharmacology
  • Cysteine / chemistry*
  • Cysteine / genetics
  • Flavins / metabolism
  • Humans
  • Kynuramine / metabolism
  • Liver / enzymology
  • Monoamine Oxidase / chemistry*
  • Monoamine Oxidase / metabolism*
  • Monoamine Oxidase Inhibitors / chemistry
  • Monoamine Oxidase Inhibitors / pharmacology*
  • Mutagenesis, Site-Directed
  • Mutation / genetics*
  • Oxidation-Reduction
  • Pichia / enzymology
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / metabolism
  • Serotonin / metabolism
  • Substrate Specificity
  • Sulfhydryl Compounds / metabolism

Substances

  • Benzylamines
  • Cyclopropanes
  • Flavins
  • Monoamine Oxidase Inhibitors
  • Recombinant Proteins
  • Sulfhydryl Compounds
  • Serotonin
  • Kynuramine
  • cyclopropylamine
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Monoamine Oxidase
  • Cysteine
  • Alanine